Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics

Specificaties
Gebonden, blz. | Engels
Springer International Publishing | 2019
ISBN13: 9783030309992
Rubricering
Springer International Publishing e druk, 2019 9783030309992
Onderdeel van serie Springer Theses
€ 120,99
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.

Specificaties

ISBN13:9783030309992
Taal:Engels
Bindwijze:gebonden
Uitgever:Springer International Publishing

Inhoudsopgave

<div><p>Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management.- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout.- Label –Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets.- Amplification-Free Electrochemical RNA Biomarker Sensing.- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.</p><br></div>
€ 120,99
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics